Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial of Oxaloacetate in Alzheimer's Disease (TOAD)

NCT02593318 is registered in ClinicalTrials.gov with Russell Swerdlow as lead sponsor.

NCT NCT02593318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02593318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial of Oxaloacetate in Alzheimer's Disease (TOAD)
Lead sponsor
Russell Swerdlow
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2015
Completion date
September 30, 2018
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease (ad)